Search results for " production" in Articles / App Notes
Article
3rd BioProcessing Asia Preview: Q&A with John Curling
The 3rd BioProcessing Asia conference will take place November 12-15, 2018 on Langkawi, Malaysia. This week, Bioprocess Development Forum talks with John Curling, Conference Chair, about the upcomin…
Article
Best Practices for Data Integrity
In serious cases, bad data integrity could lead to an FDA-mandated shutdown of production. I’d say just about every biopharmaceutical manufacturer understands this concern. So, out of fear, they inves…
Article
Process Chromatography Selection for Downstream Processing Applications
Membrane adsorbers have been available for more than a decade, and while their acceptance has increased in the past few years, their use may be more applicable for early-stage molecules and in the pro…
Article
Continuous Chromatography: Trends, Definitions and Approaches
Process Development Forum speaks with Karol Lacki, Customer Collaborations Leader at Cytiva, about continuous chromatography.
There is a lot of attention being paid to continuous chromat…
Article
Report: Branded Biopharms Most Exposed to Biosimilar Competition
In a new report on the global biosimilar drugs market, Biosimilars: Parsing the Industry's Pipelines, Moody's Investors Service reports that while biosimilar products have been launched in Asia and …
Article
Flexibility in Biopharmaceutical Manufacturing
Maintaining flexibility in biopharmaceutical manufacturing can deliver positive results.
By: Simon Chalk
BioPharm International
There is a high degree of consensus in the biomanuf…
Article
Process Development: 2020 Reflections and 2021 Possibilities
Moving from optional to essential bioprocess components, one process the industry often relies on for the cost-effective production of therapeutics is process chromatography, particularly for monoclon…
Article
Can Vaccine Development Be Safely Accelerated?
The rapid discovery approach and the manufacturing agility of mRNA vaccine design and production also make it an effective platform technology.
Just 42 days after sequence selection, Moderna sh…
Article
Getting Ahead of the Game in Cell and Gene Therapy
Here, we present an article based on an interview with Carol Knevelman, Vice President, Head of Process R&D at Oxford Biomedica, who shared a case study on large-scale lentiviral vector production at …
Article
Intensified Chromatography Strategies
The blockbuster drug era is over and drug manufacturers are now striving for a more diversified portfolio by targeting a greater number of monoclonal antibody (mAb) products at lower production volu…